Deep Vein Thrombosis: Diagnosis & Treatment Reginald E. Smith ...

More documents

Recommendations

Info

Bleeding Management Withhold Dabigatran/Rivaroxaban 5 Half Lives 2.5-3.5 days for Dabigatran, 1.8 – 2.5 Days Rivaroxaban) Blood Transfusion Medical/Surgical Measures
Page 1 and 2:
Deep Vein Thrombosis: Diagnosis & T
Page 3 and 4:
Fail or Win 3
Page 6 and 7:
Virchow’s Triad and Thrombus Form
Page 8 and 9:
Pathophysiology of DVT Most Often
Page 11 and 12: Late Presentation Is Common The Ris
Page 13 and 14: WELLS Scale For Pretest Probability
Page 15 and 16: Sensitivity & Specificity Of D-Dime
Page 17 and 18: Compression Ultrasound Lower Extrem
Page 19 and 20: Deep Vein Clots Are Big Measured In
Page 21 and 22: Pulmonary Embolism 21
Page 23 and 24: Pulmonary Embolism: A Life-threaten
Page 25 and 26: Diagnostic Testing for PE CT Angiog
Page 27 and 28: Acute Pulmonary Embolism R Axis Dev
Page 29: Grade IA Symptomatic Proximal DVT G
Page 32 and 33: Therapy: Do We Need To Anticoagulat
Page 34 and 35: Overlapping Heparins, LMWH or Fonda
Page 36 and 37: Does SYMPTOMATIC Calf DVT Require T
Page 38 and 39: Cancer Associated Thrombosis 38
Page 40 and 41: Treatment Of Cancer Associated Thro
Page 42 and 43: Novel Anticoagulants: The Future of
Page 44 and 45: New Oral Anticoagulant Agents In De
Page 46 and 47: Dabigatran etexilate: a novel direc
Page 48 and 49: RE-LY ® - study design Atrial fibr
Page 50 and 51: Major bleeding rates 3.50 3.00 2.50
Page 52 and 53: Most common adverse events Dabigatr
Page 54 and 55: RE-COVER TM Trial Design Singledumm
Page 56 and 57: Cumulative risk of first event of m
Page 58 and 59: Dabigatran: How To Measure Effect?
Page 62 and 63: Rivaroxaban
Page 64 and 65: Rivaroxaban Is Structurally Similar
Page 66: Effect of Rivaroxaban On Coagulatio
show all

Deep Vein Thrombosis: Diagnosis & Treatment Reginald E. Smith ...

Create successful ePaper yourself

Delete template?

Save as template?